ConductScience.org, home

Paper42801232PubMed

Investigation of the Residual Tumor Burden and Prognosis of Breast Cancer.

Rezende AS and 4 others. Breast Cancer (Dove Med Press), 2026.

Cite this record

ConductScience Library. Investigation of the Residual Tumor Burden and Prognosis of Breast Cancer. Papers, record 42801232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42801232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Investigation of the Residual Tumor Burden and Prognosis of Breast Cancer.
Journal
Breast Cancer (Dove Med Press)
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-09-28

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rezende ASAngela de Salleshttps://orcid.org/0000-0003-1443-8057
2Gutman TCFTeresa Cristina Ferreira
3Cunha KSKarin Soares
4Rodrigues FRFabiana Resende
5Lopes VGSVânia Gloria Silami

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128075166The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis.Future Oncol2017https://conductscience.org/library/papers/28075166PubMed
234902335Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.Lancet Oncol2022https://conductscience.org/library/papers/34902335PubMed
335626173Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature).Cancers (Basel)2022https://conductscience.org/library/papers/35626173PubMed
432202537Histological type and typing of breast carcinomas and the WHO classification changes over time.Pathologica2020https://conductscience.org/library/papers/32202537PubMed
517443564Preoperative chemotherapy for women with operable breast cancer.Cochrane Database Syst Rev2007https://conductscience.org/library/papers/17443564PubMed
634620608Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy.J Clin Pathol2023https://conductscience.org/library/papers/34620608PubMed
717785706Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.J Clin Oncol2007https://conductscience.org/library/papers/17785706PubMed
834529000Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.JAMA Oncol2021https://conductscience.org/library/papers/34529000PubMed
941111043Clinical Benefit of Adjuvant Capecitabine According To Residual Cancer Burden in Patients With Triple-Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy.Clin Breast Cancer2026https://conductscience.org/library/papers/41111043PubMed
1030871490Prognostic models for breast cancer: a systematic review.BMC Cancer2019https://conductscience.org/library/papers/30871490PubMed
1139323311Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer Patients Treated With Mastectomy: Indications for Treatment and Oncological Outcomes.Eur J Breast Health2024https://conductscience.org/library/papers/39323311PubMed
1234288593Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.Cancer Commun (Lond)2021https://conductscience.org/library/papers/34288593PubMed
1332579551Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy.PLoS One2020https://conductscience.org/library/papers/32579551PubMed
1438572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1525932963Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.Mod Pathol2015https://conductscience.org/library/papers/25932963PubMed
1639362047Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study.Eur J Surg Oncol2024https://conductscience.org/library/papers/39362047PubMed
1720941809Biological markers in breast cancer prognosis and treatment.J BUON2010https://conductscience.org/library/papers/20941809PubMed
1829096890Breast Cancer Epidemiology, Prevention, and Screening.Prog Mol Biol Transl Sci2017https://conductscience.org/library/papers/29096890PubMed
1925114845Pathogenesis, prevention, diagnosis and treatment of breast cancer.World J Clin Oncol2014https://conductscience.org/library/papers/25114845PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42801232

GET https://conductscience.org/api/papers/v1/42801232/authors